Marinomed Biotech Forms Long-Term Solv4U Partnership with Shanghai SPH Sinae Pharmaceuticals
Marinomed Biotech forms long-term Solv4U technology partnership with SPH Sinae Pharmaceutical Laboratories.
Marinomed's Solv4U technology partnerships will address challenges related to solubility and bioavailability, thus bolstering API formulation development during the crucial stages of drug discovery and early development.
The alliance between Marinomed and SPH Sinae holds immense promise for the future. Both entities will jointly file a patent for the innovative product resulting from their synergistic efforts.
SPH Sinae will make use of Marinosolv Technology for active pharmaceutical ingredients (APIs) dissolution in orally inhaled and nasal drug products. The partnership with SPH Sinae serves as a compelling catalyst for Marinomed to enhance its commitment towards furthering and broadening the Solv4U platform.
This collaboration represents a strategic move towards leveraging Solv4U's clinically proven technology to enhance the development of more efficacious and sustainable pharmaceuticals for the ultimate benefit of patients.
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!